Home / Brands / The Compounding Pharmacy of America
The Compounding Pharmacy of America Recalls
383 recalls on record · September 23, 2015 to February 21, 2018 · Drugs
Recalls by year
15
18
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/2/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/2/20) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/1/22) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/1/22) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/1/20) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/1/20) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/1/10) (MFG) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/1/10) Injectable, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/0.5/10) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (30/0.5/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (25/2.5/10) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (25/2.5/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (22.5/0.83/8.3) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (20/2.5/20) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (20/1/10) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (18/0.6/5.88) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (18 mg/0.6 mg/5.88 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (17.7/0.59/6) (MFG) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (17.7 mg/1 mg/10 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (17.7 mg/0.59 mg/6 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (17 mg/0.5 mg/6 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (15 mg/0.5 mg/5 mcg) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Tri-Mix (10/0.174/16) Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Tri-Blend 200 mg/ml (10 ml Sesame Oil) Injection, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 40 mg/ml Injectable, 5 Sesame, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 250 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Amer
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 40 mg/ml (10 ml Sesame Oil), Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compoundi
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 220 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Amer
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 250 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Amer
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 50 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Ameri
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility